/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Cocktail Bar
5.15.20, 5:00 PM EDT on neoscope
Pharma Company Claims to Find Part of COVID-Fighting Cocktail
There's Hope
5.15.20, 2:36 PM EDT on neoscope
Good News: Human Body Builds "Robust" Immune Response to COVID
More Bad News
5.15.20, 11:25 AM EDT on neoscope
Report: COVID Has Spread to the World's Largest Refugee Camp
Kidney Failure
5.15.20, 10:56 AM EDT on neoscope
Study: COVID Patients Suffering Acute Kidney Damage
Inner Workings
5.14.20, 11:35 AM EDT on neoscope
Scientists Have a Promising New Idea to Defeat the Coronavirus
Bad News Dept.
5.14.20, 10:24 AM EDT on neoscope
WHO: The Coronavirus Might Be Here Forever
Blood for Bill
5.14.20, 10:20 AM EDT on neoscope
Microsoft Is Buying COVID-19 Patients' Blood for Biotech Research
Long Weekend
5.13.20, 11:02 AM EDT on neoscope
Researchers: Working Just 8 Days Per Month Could Help Fight COVID
Exaggerated Claims
5.12.20, 12:45 PM EDT on neoscope
CityMD Wrongly Told 15,000 Patients They Were Immune to COVID-19
Dire Warning
5.12.20, 11:50 AM EDT on neoscope
Fauci: Reopening Too Soon Could Lead to "Suffering and Death"
Big Push
5.12.20, 11:30 AM EDT on neoscope
After Six New Cases, Wuhan Plans to Test All 11 Million Residents
Resurgence
5.11.20, 3:59 PM EDT on neoscope
There's a Resurgence of Coronavirus Cases in China
  • Previous
  • 1
  • ...
  • 173
  • 174
  • 175
  • ...
  • 217
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.